These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32414721)

  • 21. The Prediction of In-Hospital Mortality in Decompensated Cirrhosis with Acute-on-Chronic Liver Failure.
    Wong F; Reddy KR; Tandon P; Lai JC; Jagarlamudi N; Weir V; Kok B; Kalainy S; Srisengfa YT; Albhaisi S; Reuter B; Acharya C; Shaw J; Thacker LR; Bajaj JS
    Liver Transpl; 2022 Apr; 28(4):560-570. PubMed ID: 34564944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol consumption and liver cirrhosis mortality after lifting ban on beer sales in country with state alcohol monopoly.
    Tyrfingsson T; Olafsson S; Bjornsson ES; Rafnsson V
    Eur J Public Health; 2015 Aug; 25(4):729-31. PubMed ID: 25085471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Usefulness of model for end-stage liver disease score for predicting mortality after intra-abdominal surgery in patients with liver cirrhosis in a single hospital].
    Song CS; Yoon MY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2011 Jun; 57(6):340-5. PubMed ID: 21694485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Model for End-Stage Liver Disease score: an independent prognostic factor of mortality in injured cirrhotic patients.
    Inaba K; Barmparas G; Resnick S; Browder T; Chan LS; Lam L; Talving P; Demetriades D
    Arch Surg; 2011 Sep; 146(9):1074-8. PubMed ID: 21576598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.
    Hernaez R; Liu Y; Kramer JR; Rana A; El-Serag HB; Kanwal F
    J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. qSOFA score not predictive of in-hospital mortality in emergency patients with decompensated liver cirrhosis.
    Müller M; Schefold JC; Leichtle AB; Srivastava D; Lindner G; Exadaktylos AK; Pfortmueller CA
    Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):724-732. PubMed ID: 30132026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Alcohol Taxes as a Public Health Opportunity to Reduce Liver Transplant Listings for Alcohol-Related Liver Disease.
    Shen NT; Bray J; Wahid NA; Raver M; Hutchison N; Brown RS; Schackman BR
    Alcohol Clin Exp Res; 2020 Nov; 44(11):2307-2315. PubMed ID: 32944958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of different prognostic scores in liver transplantation decision-making for acute-on-chronic liver failure].
    Xu MM; Wu Y; Li SS; Geng N; Lu W; Duan BW; Duan ZP; Li GM; Li J; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):574-581. PubMed ID: 37400380
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosis.
    Elkrief L; Ganne-Carrié N; Manceau H; Tanguy M; Valainathan SR; Riescher-Tuczkiewicz A; Biquard L; Barget N; Chaffaut C; Louvet A; Paradis V; Ziol M; Bæk R; Jørgensen MM; Van Niel G; Coly PM; Hammoutène A; Dujardin F; Peoc'h K; Poynard T; Chevret S; Rautou PE;
    J Hepatol; 2023 Oct; 79(4):910-923. PubMed ID: 37302582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol-Associated Liver Disease.
    Otero Sanchez L; Karakike E; Njimi H; Putignano A; Degré D; Hites M; Jacobs F; Moreno C; Trepo E; Gustot T
    Hepatology; 2021 Nov; 74(5):2714-2724. PubMed ID: 34046927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective and prospective validation of model for end-stage liver disease (MELD) score in predicting mortality in patients of alcoholic liver disease.
    Mallaiyappan M; Sawalakhe NR; Sasidharan M; Shah DK; Rathi PM; Bhatia SJ
    Trop Gastroenterol; 2013; 34(4):252-8. PubMed ID: 25046888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Role of MELD-Lactate in Cirrhotic Patients' Short- and Long-Term Prognosis, Stratified by Causes of Cirrhosis.
    Chen XF
    Can J Gastroenterol Hepatol; 2022; 2022():8449579. PubMed ID: 35392026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?
    Williamson KD; Gill MG; Andrews JM; Harley HA
    Intern Med J; 2016 Dec; 46(12):1407-1413. PubMed ID: 27643595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rural-Urban Differences in In-Hospital Mortality Among Admissions for End-Stage Liver Disease in the United States.
    Ross KH; Patzer RE; Goldberg D; Osborne NH; Lynch RJ
    Liver Transpl; 2019 Sep; 25(9):1321-1332. PubMed ID: 31206223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting Outcomes in Trauma Patients With Cirrhosis Using Model for End-Stage Liver Disease Score: A Retrospective Study.
    Natkha VP; Southerland P; Almekdash MH; Keesair R; Dhanasekara CS; Dissanaike S
    Am Surg; 2023 Jun; 89(6):2383-2390. PubMed ID: 35521931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding.
    Xavier SA; Vilas-Boas R; Boal Carvalho P; Magalhães JT; Marinho CM; Cotter JB
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):652-658. PubMed ID: 29438135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infections increase the risk of decompensation and death in patients with early alcohol-related liver disease.
    Johansen S; Langkjær S; Rasmussen DN; Israelsen M; Torp N; Lindvig K; Kjærgaard M; Hansen JK; Hansen CD; Thorhauge K; Andersen P; Detlefsen S; Juel HB; Justesen US; Hansen T; Krag A; Thiele M; ;
    JHEP Rep; 2024 Apr; 6(4):101016. PubMed ID: 38486819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study.
    Yang J; Yan B; Yang L; Li H; Fan Y; Zhu F; Zheng J; Ma X
    BMC Gastroenterol; 2018 Nov; 18(1):161. PubMed ID: 30384828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis.
    Zanetto A; Pelizzaro F; Campello E; Bulato C; Balcar L; Gu W; Gavasso S; Saggiorato G; Zeuzem S; Russo FP; Mandorfer M; Reiberger T; Trebicka J; Burra P; Simioni P; Senzolo M
    J Hepatol; 2023 Feb; 78(2):301-311. PubMed ID: 36150575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.